Article Data

  • Views 732
  • Dowloads 153

Original Research

Open Access

Leukocytosis and thrombocytosis as prognostic factors for women with uterine cervical cancer

  • Y. Murata1
  • Y. Miyahara1
  • K. Suzuki1
  • S. Wakahashi1
  • T. Sudo2
  • S. Nagao2
  • S. Yamaguchi2
  • Y. Ebina1
  • H. Yamada1,*,

1Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe

2Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi (Japan)

DOI: 10.31083/j.ejgo.2020.01.4886 Vol.41,Issue 1,February 2020 pp.93-97

Published: 15 February 2020

*Corresponding Author(s): H. Yamada E-mail:


Purpose of Investigation: The aim of this study was to evaluate whether leukocytosis and thrombocytosis prior to treatment was associated with the prognosis of women with uterine cervical cancer. Materials and Methods: The authors assessed 2,267 women who were diagnosed as having FIGO Stages I-IV uterine cervical cancer and were followed up for at least five years. The age, clinical stage, histology, leukocytosis, and thrombocytosis at the initial diagnosis were evaluated for overall survival (OS). Results: Leukocytosis and thrombocytosis were identified in 315 and in 134 women, respectively. Fifty-eight had both conditions. Multivariable analysis revealed that age [hazard ratio (HR) 1.7, p < 0.001], advanced FIGO Stage (4.8, p < 0.001), histology (2.0, p < 0.001), leukocytosis (1.5, p < 0.01), and thrombocytosis (2.0, p < 0.01) were independent factors for decreased OS. OS of women with both thrombocytosis and leukocytosis was the worst (p < 0.01). Conclusion: Leukocytosis and thrombocytosis were independently associated with decreased OS in women with uterine cervical cancer.


Cervical cancer; Leukocytosis; Thrombocytosis; Prognosis.

Cite and Share

Y. Murata,Y. Miyahara,K. Suzuki,S. Wakahashi,T. Sudo,S. Nagao,S. Yamaguchi,Y. Ebina,H. Yamada. Leukocytosis and thrombocytosis as prognostic factors for women with uterine cervical cancer. European Journal of Gynaecological Oncology. 2020. 41(1);93-97.


[1] Boyce J.G., Fruchter R.G., Nicastri A.D., DeRegt R.H., Ambiavagar P.C., Reinis M., et al.: “Vascular invasion in Stage I carcinoma of the cervix”. Cancer, 1984, 53, 1175.

[2] Zreik T.G., Chambers J.T., Chambers S.K.: “Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer”. Obstet. Gynecol., 1996, 87, 741.

[3] Delgado G., Bundy B., Zaino R., Sevin BU., Creasman WT., Major F.: “Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study”. Gynecol Oncol., 1990, 38, 352.

[4] Sevin B.U.., Lu Y., Bloch D.A., Nadji M., Koechli O.R., Averette H.E.: “Surgically defined prognostic parameters in patients with early cervical carcinoma. Amultivariate survival tree analysis”. Cancer, 1996, 78, 1438.

[5] Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., Akazawa K., Nakano H.: “Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy”. Cancer, 1992, 69, 181.

[6]Estape R.E., Angioli R., Madrigal M., Janicek M., Gomez C., Penalver M., Averette H.: “Close vaginal margins as a prognostic factor after radical hysterectomy”. Gynecol. Oncol., 1998, 68, 229.

[7]Maione P., Rossi A., Di Maio M., Gridelli C.: “Tumor-related leukocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer? ”. Lung Cancer., 2009, 66, 8.

[8]Holgersson G., Hoye E., Bergqvist M., Ekman S., Nyman J., Helsing al.: “Swedish Lung Cancer Radiation Study Group: predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer”. Acta Oncol., 2012, 51, 759.

[9]Mabuchi S., Matsumoto Y., Isohashi F., Yoshioka Y., Ohashi H., Morii al.: “Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer”. Gynecol Oncol., 2011, 122, 25.

[10]Mabuchi S., Matsumoto Y., Kawano M., Minami K., Seo Y., Sasano T., et al.: “Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature”. J. Natl. Cancer Inst., 2014, 106, 147.

[11] Qiu M.Z., Xu R.H., Ruan D.Y., Li Z.H., Luo H.Y., Teng K.Y., et al.: “Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China”. Tumour Biol., 2010, 31, 633.

[12] Mabuchi S., Matsumoto Y., Hamasaki T., Kawano M., Hisamatsu T., Mutch DG., Kimura T.: “Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer”. Int. J. Gynecol. Cancer, 2012, 22, 1545.

[13] Levin J., Conley C.L.: “Thrombocytosis associated with malignant disease”. Arch. Intern. Med., 1964, 114, 497.

[14] Cheng J., Zeng Z., Ye Q., Zhang Y., Yan R., Liang C., et al.: “The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis”. Oncotarget, 2017, 8, 24327.

[15] Schernberg A., Huguet F., Moureau-Zabotto L., Chargari C., Rivin Del Campo E., MichelSchlienger M., et al.: “External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation.”. Radiother Oncol., 2017, 124, 110.

[16] Schernberg A., Moureau-Zabotto L., Rivin Del Campo E., Escande A., Ducreux M., Nguyen F., et al.: “Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation”. Oncotarget, 2017, 8, 11579.

[17] Kozak M.M., von Eyben R., Pai J.S., Anderson E.M., Welton M.L., Shelton A.A., et al.: “The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer”. Am. J. Clin. Oncol., 2017, 40, 405.

[18] Stone R.L., Nick A.M., McNeish I.A., Balkwill F., Han H.D., Bottsford-Miller J., et al.: “Paraneoplastic thrombocytosis in ovarian cancer”. N. Engl. J. Med., 2012, 366, 610.

[19] Matsumoto Y., Mabuchi S., Muraji M., Morii E., Kimura T.: “Squamous cell carcinoma of the uterine cervix producing granulocyte colony-stimulating factor: a report of 4 cases and a review of the literature”. Int. J. Gynecol. Cancer, 2010, 20, 417.

[20] Gutschalk C.M., Herold-Mende C.C., Fusenig N.E., Mueller M.M.: “Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo”. Cancer Res., 2006, 66, 8026.

[21] Labelle M., Begum S., Hynes R.O.: “Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis”. Cancer Cell, 2011, 20, 576.

[22] Srivani R., Nagarajan B.: “A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer”. Int. J. Gynecol. Cancer, 2003, 13, 331.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time